Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 55 min ago

Pharmacology & toxicology

3,013 studies233 in 7 days1,447 in 30 days

Filters
Type
Date
Clear

Latest

3,013 studies

  1. Iron-sulfur cluster delivery by SufT enables oxidative stress resistance and intracellular survival in Mycobacterium abscessus
    Valentin Berdal, Dorian Baude, Zhuoyan Chen +12
    Current Research in Microbial SciencesPeer-reviewedCC BY 4.0Full textInfectious diseasePharmacology & toxicologyHAL
  2. 2-Amino-3-methylimadazo[4,5-f]quinoline (IQ) induces cytochrome P450 1A through the canonical AhR-XRE pathway in human hepatocytes
    Minna A. Choi, Medjda Bellamri, Arnaud Tête +2
    Archives of ToxicologyPeer-reviewedCC BY-NC-ND 4.0Full textPharmacology & toxicologyHAL
  3. Quality by Design (QbD) Empowered by IVIVR Modelling: A Predictive Approach for Drug Formulation Development
    Dr Mohamed Baraadid, Nadia Ibntabet, Karim Lahlou
    International Journal of Pharmaceutical Sciences Review and ResearchPeer-reviewedLicence not statedFull textPharmacology & toxicologyHAL
  4. Trends in psychotropic drug use in nursing home residents with dementia and their association with regulatory changes: A routine care data analysis from 2016 to 2023
    Charlotte A. W. Albers, Fenne Wouters, Martine C. de Bruijne +2
    PLOS OnePeer-reviewedCC BY 4.0Full textNeurologyPharmacology & toxicologyPsychiatry & mental healthPLOSPMC
  5. Environmental enrichment is associated with changes in the gut microbiome and resistome of captive pythons
    Ji Chen, Yu-Qi Cheng, Lin-Ping Fan +7
    PLOS OnePeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPLOSPMC
  6. Pharmacogenomics-guided cardiovascular therapy in low- and middle-income countries: A systematic review of barriers, equity gaps, and pathways to personalized medicine
    Md. Farid Reza Mashfi, Sumiya Sharmin Mou, Monalisa Riya +5
    PLOS Global Public HealthPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPLOSPMC
  7. Identification and validation of biomarkers associated with mitochondrial dynamics dysfunction in Parkinson’s disease based on GEO datasets
    Dawei Gong, Guanyu Li, Ming Li +4
    PLOS OnePeer-reviewedCC BY 4.0Full textNeurologyPharmacology & toxicologyPLOSPMC
  8. Invited Perspective: Improving Our Approach to Studies of Outdoor Artificial Light at Night and Cancer Risk
    Parveen Bhatti, Manolis Kogevinas
    Environmental health perspectivesPeer-reviewedCC BY-NC-NDFull textPharmacology & toxicologyEurope PMC
  9. Population level immunity to measles and rubella 5 years before and after the MR campaign in urban Vellore, South India
    Ramya Madhavan, Akilandeswari Eswaran, Vaishnavi Gandhi +10
    Human Vaccines & ImmunotherapeuticsPeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
  10. CFTR regulation of ROS-mediated cellular injury and immune dysregulation in cystic fibrosis
    Cheng Shi, Minghui Zhang, Honghong Wang +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyDOAJFrontiersCrossref
  11. Mitochondria-associated ferroptosis in ischemic stroke: Pathophysiological evolution, interorganelle crosstalk, and therapeutic targeting
    Mengge Zhang, Yuzhe Cai, Qianru Zeng +7
    Pharmacological ResearchPeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
  12. Strategic selection of TPD technologies based on disease pathology: from mechanistic diversity to clinical implementation
    Dongxin Yi, Jingyuan Zhao, Shuai Li +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  13. Multidimensional analysis of the pathological mechanisms of infantile hemangioma: metabolic reprogramming, immune remodeling, and programmed cell death
    Haoyi Liang, Haizhou Pan, Yangjinyi An +6
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  14. Traditional Paeonia radix alba formulas and their bioactive metabolites: a narrative review focusing on hepatoprotection in chronic liver diseases
    Yanqi Li, Jinmin Shen, Xiaozhong He +7
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  15. Editorial: 4Rs in ethnopharmacology - reduce, refine, replace and responsibility using animal models
    Aiping Lyu, Xiaojuan He, Michael Heinrich +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  16. Progression-free survival of 23 months with second-line trastuzumab deruxtecan in HER2-positive gastroesophageal junction adenocarcinoma: a case report
    Yuanmei Dong, Li Zhang, Lan Zhao +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  17. Justicia procumbens suppresses high-fat diet-induced weight gain in mice and adipogenesis in 3T3-L1 cells with inhibition of AKT and STAT3 phosphorylation
    Yeeun Kim, Seoyeon Lee, Jun Hyung Park +10
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefDOAJ
  18. A tumor-responsive nanoplatform orchestrating multiplexed macrophage engagers and immune checkpoint blockade for triple-negative breast cancer immunotherapy
    Bo Xiang, Tao Liu, Wei Wang +3
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  19. Tanshinone IIA in colorectal cancer: preclinical mechanisms, therapeutic sensitization, and translational prospects
    Siqin Li, Jingzhi Zhang, Xiaoyu Zhang +6
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  20. Sulodexide versus low-molecular-weight heparin in critically ill neonates: a propensity score–matched retrospective cohort study
    Mengsha Wei, Yuanguo Xiong, Fan Zhang +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  21. Effect of compound kushen injection on immune function in patients with lung cancer: a systematic review and meta-analysis
    Yu Xiong, Yutong Cai, Lin Wang +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  22. Oral anticoagulants and the risk of acute kidney injury: a retrospective real-world cohort study using overlap propensity score weighting
    Ping Li, Fang-Yuan Tian, Hao-Bo Liu +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyFrontiersCrossrefDOAJ
  23. Paeoniflorin ameliorates Parkinson’s disease by promoting autophagy to inhibit A1 phenotype astrocyte activation
    Yijiao Long, Lihui Wang, Jun Yin +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  24. Engineering a multifunctional LL37-TP5 hybrid peptide with potent antimicrobial endotoxin-neutralizing and anti-inflammatory properties
    Baseer Ahmad, Kiran Khurshid, Wei Xubiao +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  25. Human amniotic mesenchymal stem cell-derived exosomes alleviate cerebral Palsy–Associated neuronal damage via TSC1/mTOR/ULK1 autophagy suppression and PINK1/Parkin mitophagy restoration
    Yu Zhou, Fuli Yan, Zhouzhou Li +3
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref